Overview

Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to investigate pharmacokinetics of insulin detemir in healthy Taiwanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc